OrbusNeich Medical Group Holdings Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 136.82 million compared to USD 116.46 million a year ago. Net income was USD 18.49 million compared to net loss of USD 4.44 million a year ago.

Basic earnings per share from continuing operations was USD 0.0317 compared to basic loss per share from continuing operations of USD 0.0077 a year ago. Diluted earnings per share from continuing operations was USD 0.0255 compared to diluted loss per share from continuing operations of USD 0.0077 a year ago.